| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 36,380 | 34,956 | 36,232 | 45,616 | | Cost of Revenue | 23,921 | 23,559 | 24,345 | 33,152 | | | Gross Profit | 12,459 | 11,397 | 11,887 | 12,464 | | | Operating Expenses | | Research Development | 2,813 | 2,973 | 3,251 | 3,518 | | Selling General and Administrative | 6,452 | 7,420 | 7,357 | 7,042 | | Non Recurring | 16 | 534 |
-
| 159 | | Others | 795 | 917 | 899 | 887 | | | | Total Operating Expenses | 10,076 | 11,844 |
-
| 11,606 | | | | Operating Income or Loss | 2,383 | (447) | 380 | 858 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 1 | 5 | (73) | | Earnings Before Interest And Taxes | 2,221 | (446) | 385 | 785 | | Interest Expense | (78) | 61 | 81 | (18) | | Income Before Tax | 2,299 | (507) | 304 | 803 | | Income Tax Expense | 423 | (160) | 59 | 385 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,876 | (347) | 245 | 418 | | | Non-recurring Events | | Discontinued Operations | (157) | (87) | (196) | (652) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,719 | (434) | 49 | (234) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,719 | ($434) | $49 | ($234) |
|
0.49% Nasdaq 
Income Statement
